E, G. G., R, C. C., J, B., A, R. A., BJ, M., JI, M. S., . . . N, d. P. (2023). ProsTAV, a novel blood-based test for biopsy decision management in significant prostate cancer. The Prostate, 83(14), 1323. https://doi.org/10.1002/pros.24594
Chicago Style (17th ed.) CitationE, Gómez Gómez, et al. "ProsTAV, a Novel Blood-based Test for Biopsy Decision Management in Significant Prostate Cancer." The Prostate 83, no. 14 (2023): 1323. https://doi.org/10.1002/pros.24594.
MLA (9th ed.) CitationE, Gómez Gómez, et al. "ProsTAV, a Novel Blood-based Test for Biopsy Decision Management in Significant Prostate Cancer." The Prostate, vol. 83, no. 14, 2023, p. 1323, https://doi.org/10.1002/pros.24594.
Warning: These citations may not always be 100% accurate.